JPS5363397A - Antibiotics 890a - Google Patents

Antibiotics 890a

Info

Publication number
JPS5363397A
JPS5363397A JP13735677A JP13735677A JPS5363397A JP S5363397 A JPS5363397 A JP S5363397A JP 13735677 A JP13735677 A JP 13735677A JP 13735677 A JP13735677 A JP 13735677A JP S5363397 A JPS5363397 A JP S5363397A
Authority
JP
Japan
Prior art keywords
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13735677A
Other languages
Japanese (ja)
Other versions
JPS6310998B2 (en
Inventor
Jiee Kashidei Patoritsuku
Bii Tsuinmaaman Shierudon
Bii Chiyunatsuku Jiyosefuiino
Erunanden Sebasuchian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5363397A publication Critical patent/JPS5363397A/en
Publication of JPS6310998B2 publication Critical patent/JPS6310998B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP13735677A 1976-11-17 1977-11-17 Antibiotics 890a Granted JPS5363397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74295876A 1976-11-17 1976-11-17

Publications (2)

Publication Number Publication Date
JPS5363397A true JPS5363397A (en) 1978-06-06
JPS6310998B2 JPS6310998B2 (en) 1988-03-10

Family

ID=24986929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13735677A Granted JPS5363397A (en) 1976-11-17 1977-11-17 Antibiotics 890a

Country Status (10)

Country Link
JP (1) JPS5363397A (en)
CH (1) CH634104A5 (en)
DE (1) DE2751303A1 (en)
DK (1) DK487977A (en)
ES (1) ES463973A1 (en)
FR (1) FR2371448A1 (en)
GB (1) GB1595233A (en)
NL (1) NL7712092A (en)
PT (1) PT67268B (en)
SE (1) SE433621B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609766A1 (en) * 1975-03-15 1976-09-23 Beecham Group Ltd NEW ANTIBIOTIC, METHOD FOR ITS MANUFACTURING AND MEDICINAL PREPARATIONS CONTAINING THIS COMPOUND

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609766A1 (en) * 1975-03-15 1976-09-23 Beecham Group Ltd NEW ANTIBIOTIC, METHOD FOR ITS MANUFACTURING AND MEDICINAL PREPARATIONS CONTAINING THIS COMPOUND

Also Published As

Publication number Publication date
DK487977A (en) 1978-05-18
JPS6310998B2 (en) 1988-03-10
ES463973A1 (en) 1978-11-16
SE7712430L (en) 1978-05-18
PT67268B (en) 1979-10-08
CH634104A5 (en) 1983-01-14
FR2371448B1 (en) 1980-03-14
SE433621B (en) 1984-06-04
DE2751303A1 (en) 1978-05-18
PT67268A (en) 1977-12-01
FR2371448A1 (en) 1978-06-16
NL7712092A (en) 1978-05-19
GB1595233A (en) 1981-08-12

Similar Documents

Publication Publication Date Title
HK46182A (en) New antibiotics
JPS5248686A (en) Antibiotics
JPS52128365A (en) Antibiotics compounds
ZA766306B (en) Antibiotics
JPS52131596A (en) Antibiotics
JPS5291890A (en) Betaalactum system antibiotics
JPS5326329A (en) Antibiotics
JPS51118701A (en) Antibiotics
ZA773288B (en) Antibiotic bl580delta
ZA766308B (en) Antibiotics
GB1541512A (en) Antibiotic compounds
ZA77715B (en) 7-substituted-ureido 3-carbamoyloxymethylcephalosporins antibiotics
JPS52105193A (en) Antibiotics
JPS5344615A (en) Silverrcontaining antibiotic
JPS52277A (en) New antibiotics
JPS5363396A (en) Antibiotics 890a
JPS52105293A (en) Antibiotic composition
JPS5320492A (en) Novel antibiotic
JPS5326328A (en) Antibiotics
JPS5392796A (en) Antibiotics
JPS52121455A (en) Toothhbruching things
JPS533533A (en) Antibiotic composition
JPS5283992A (en) Novel antibiotic
JPS5326395A (en) Novel antibiotic
JPS5363397A (en) Antibiotics 890a